New Study Finds Flavored Nicotine Products Popular Among Teenagers

Aug.08.2022
Flavored nicotine products, including gum and lozenges, are popular among Southern California teens, according to a new study.

Nicotine seasoning products, which do not contain tobacco ingredients, are being sold in increasing quantities without approval from the US Food and Drug Administration. However, researchers have not investigated their use among American teenagers.


In a new study published this week in the Journal of Pediatrics, researchers from the Keck School of Medicine at the University of Southern California surveyed over 3,500 adolescents in Southern California about their use of nicotine products. Oral nicotine products ranked second, with 3.4% of teens reporting using them at least once and 1.7% reporting use within the past six months. E-cigarettes were the most popular nicotine product, with 9.6% of teens using them at least once within the past six months and 5.5% reporting use. Cigarettes, cigars, hookah, and other products were not as popular.


The primary author of the study, Alyssa F, stated, "It is surprising that these new flavored oral nicotine products are the second most commonly used product in our sample, following only e-cigarettes." Exposure to nicotine during adolescence can damage brain development, leading to learning, memory, and attention issues, as well as nicotine addiction.


Our findings are concerning because these products typically contain high nicotine levels, and we know that this is harmful to teenagers, and they can be easily hidden. Dr. Harlow also stated that they are often flavored, which can be appealing to teenagers, such as 'cherry bomb' and 'fruit mix'.


Popularity and differences.


The research team collected data in 2021 as part of the Southern California Adolescent Behavior Health Study. The participants included 3,516 ninth and tenth grade students from 11 high schools in Los Angeles, Riverside, San Bernardino, Orange and Inland Empire Counties.


Following electronic cigarettes, non-tobacco-flavored nicotine products (gum, lozenges, tablets, and gum) are the most commonly used products. Combustible tobacco products rank third, with 2% of adolescents reporting having used cigarettes, cigars, cigarillos, or hookah, and 1.3% of adolescents having used one or more of these items in the past six months. Less than 1% of adolescents have ever or in the past six months used other nicotine products such as pouches or snuff. The use of flavored nicotine oral products is more common among adolescents, who have also used other nicotine products such as cigarettes or electronic cigarettes.


Researchers have also found higher usage rates of flavored oral nicotine products among Hispanic adolescents, females, and those identified as LGBTQ.


Harlow stated, "Some of these subgroups of people are young individuals who have consistently been affected by tobacco-related disparities." "It is important that we continue to monitor the usage of these products among young people to determine the potential impact of these disparities.


Monitoring the use of nicotine.


A nationwide survey monitoring the use of nicotine among teenagers, including the Behavior Risk Factor Surveillance System by the Centers for Disease Control and Prevention and the tobacco and health population assessment by the Food and Drug Administration, has not yet been tracking new flavored oral nicotine products. Given the popularity of these products in current samples and their potential appeal to young people, it is crucial to track their popularity among teenagers and young adults, according to Harlow.


She said, "At present, we really don't know what impact it has on public health. That's why implementing national-level monitoring is the first and most important step.


While these products may cause harm to young people, they offer a potentially less harmful alternative for adults seeking to quit smoking or use electronic cigarettes. Harlow and her colleagues are studying young adult electronic cigarette use to determine how appealing new flavored nicotine oral products are compared to existing FDA-approved smoking cessation products.


They are continuing to gather data from a sample of high school students in Southern California and plan to conduct longitudinal analysis on the use of flavored oral nicotine products to determine how it may be associated with other behaviors such as e-cigarette and traditional smoking over time.


Regarding this study


In addition to Harlow, the other authors of the study include Erin Vogel, Alayna P. Tackett, Junhan Cho, Dae-Hee Han, Melissa Wong, Myles G. Cockburn, Steve Y. Sussman, Jennifer B. Unger, Adam M. Leventhal, and Jessica L. Barrington-Trimis from the University of Southern California's Institute for Addiction Science and Department of Population and Public Health Sciences at the Keck School of Medicine.


This work was supported by the National Cancer Institute and the FDA Center for Tobacco Products [U54CA180905], National Cancer Institute [R01CA229617], National Institute on Drug Abuse [K24DA048160; K01DA042950], and the National Heart, Lung, and Blood Institute [K01HL148907].


Statement:


This article is compiled from third-party information and is intended solely for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity or accuracy of the content. The compilation of this article is solely for communication and research within the industry.


Due to limitations in the translator's abilities, the compiled article may not fully reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic issues, as well as those involving Hong Kong, Macao, Taiwan, and foreign affairs.


The compilation of information is copyrighted to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
British American Tobacco (BAT) subsidiary Vuse Alto has recently adjusted its price tiers in U.S. convenience store channels, leveraging low-cost device kits and pod promotions to reinforce its positioning in the mid-priced closed-system e-cigarette market.
Jun.17
Special Report | China’s Tobacco Tax Debate Shifts Toward Tax Design as Policy Trade-offs Come Into Focus
Special Report | China’s Tobacco Tax Debate Shifts Toward Tax Design as Policy Trade-offs Come Into Focus
China’s tobacco tax debate is moving from whether to raise prices to how the tax system should be designed. At a Beijing forum on World No Tobacco Day, experts discussed higher specific excise taxes, minimum tax burdens and dynamic adjustments linked to income and inflation. The issue also connects to China’s broader consumption tax reform, health financing and chronic disease costs. Public reports did not mention e-cigarettes, heated tobacco, nicotine pouches or other new nicotine products.
Jun.11
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Australian State Targets Illegal Tobacco Retailers With Tougher Closure Powers
Australian State Targets Illegal Tobacco Retailers With Tougher Closure Powers
According to Reuters, Australia’s state of Victoria introduced legislation to give police and the state tobacco licensing regulator stronger powers to shut businesses selling illegal tobacco, with non-compliant operators facing fines of more than A$2.4 million and up to 20 years in prison.
Jun.05
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
According to China Customs export data analyzed by 2Firsts, China’s vape export mix continued to evolve during January-May 2026. Exports of electronic vaporisation devices (HS 85434000) increased 13.00% year on year, supported by growth in both shipment volume and average export prices. Meanwhile, exports of nicotine-containing non-combustible products (HS 24041200) declined 6.89%, with lower shipment volumes partly offset by higher average export prices.
Special Report
Jun.30
Special Report | Russian Vape Compromise Faces First Hurdles
Special Report | Russian Vape Compromise Faces First Hurdles
Russia’s regional vape-ban model is facing early legal and political tests, as Perm Krai moves ahead before federal legislation is fully adopted. The case highlights uncertainty over regional authority, concerns from business groups about market fragmentation, and the risk that pressure against regional bans could revive calls for a stricter nationwide prohibition.
Industry Insight
May.28